DHEA and DHEA-S: Adrenal Androgens and Their Role in Development, Metabolism and Hormone Balance
Dehydroepiandrosterone (DHEA) and its sulphated form (DHEA-S) are adrenal androgens produced predominantly in the zona reticularis of the adrenal cortex. Although weak androgens themselves, they serve as important precursors for the synthesis of more potent sex hormones, including testosterone and estrogens. DHEA and DHEA-S circulate in high concentrations, especially during early adulthood, and contribute to pubertal development, sexual maturation, metabolic regulation and overall endocrine balance. Their levels decline progressively with age, raising interest in their potential role in ageing, immune modulation and chronic disease. Because adrenal androgens interact closely with gonadal hormones, disturbances in their production can lead to significant clinical and developmental consequences.
What You Need to Know
Dehydroepiandrosterone (DHEA) and its sulphated form, DHEA-S, are adrenal androgens produced primarily by the zona reticularis of the adrenal cortex under the control of ACTH. Unlike cortisol and aldosterone, these hormones have relatively weak intrinsic androgenic activity and instead function mainly as precursors that can be converted in peripheral tissues into more potent sex steroids, including testosterone and oestrogens. Their role is therefore permissive and modulatory rather than directly regulatory.
Secretion of adrenal androgens increases during adrenarche, a developmental phase that typically occurs between six and eight years of age and is independent of true gonadal puberty. Rising DHEA and DHEA-S levels contribute to the appearance of pubic and axillary hair, changes in skin oil production, and early body odour, reflecting increased peripheral androgen activity. DHEA-S is the dominant circulating form because sulphation markedly prolongs its half-life, making it a stable and clinically useful marker of adrenal androgen output.
Key features that distinguish adrenal androgens from gonadal sex steroids include:
regulation primarily by ACTH rather than gonadotropins
weak direct androgenic effects with significant peripheral conversion
a prominent role in prepubertal development and pubertal transition
stable circulating levels of DHEA-S due to its long half-life
Alterations in adrenal androgen production have important physiological consequences. Excess production can lead to premature adrenarche, virilisation, menstrual disturbance, or features of hyperandrogenism, while deficiency may impair normal pubertal development and contribute to reduced libido, altered body composition, and metabolic changes in adulthood. Through their role as steroid precursors, DHEA and DHEA-S link adrenal endocrine function to sexual maturation, reproductive physiology, and long-term metabolic regulation.
Beyond the Basics
Synthesis and regulation
DHEA and DHEA-S synthesis begins with the conversion of cholesterol into pregnenolone within the adrenal cortex. In the zona reticularis, the expression and activity of specific steroidogenic enzymes favour androgen production rather than cortisol or aldosterone synthesis. DHEA is produced first and is rapidly converted to DHEA-S by the enzyme sulfotransferase SULT2A1. Sulphation markedly extends the hormone’s half-life, allowing the adrenal glands to maintain a large, stable circulating pool of androgen precursor that can be utilised by peripheral tissues as required.
ACTH is the primary regulator of adrenal androgen production, linking DHEA secretion to overall adrenal activity and stress responsiveness. However, adrenal androgen output is not regulated as tightly as cortisol. Intra-adrenal factors, peripheral metabolic signals, insulin sensitivity, prolactin, and inflammatory cytokines all appear to modulate zona reticularis function, which helps explain why adrenal androgen levels may diverge from cortisol levels in certain disease states.
DHEA as a steroid precursor
DHEA functions primarily as a substrate for the synthesis of androstenedione, testosterone, and oestrogens. This conversion occurs mainly in peripheral tissues, including the ovaries, testes, adipose tissue, skin, and brain, rather than within the adrenal gland itself. The direction of conversion depends on local enzyme expression, allowing tissues to generate androgens or oestrogens according to physiological need.
This flexibility is particularly important in life stages where gonadal hormone production declines. In post-menopausal women and ageing men, DHEA and DHEA-S become increasingly important sources of sex steroid precursors, contributing to baseline androgen and oestrogen availability despite reduced gonadal output.
Role in adrenarche and development
Adrenarche refers to the developmental increase in adrenal androgen production that occurs independently of gonadotropin-driven puberty. Rising levels of DHEA and DHEA-S precede true sexual maturation and are responsible for pubic and axillary hair development, changes in sweat composition, body odour, and mild sebaceous gland activity.
The timing of adrenarche varies but is tightly linked to maturation of the zona reticularis. Abnormal timing carries clinical significance. Premature adrenarche may signal early androgen excess or enzyme dysregulation, while delayed or absent adrenarche can reflect adrenal insufficiency or impaired steroidogenesis, particularly when accompanied by other signs of endocrine dysfunction.
Physiological functions beyond reproduction
Although DHEA itself has weak androgenic activity, accumulating evidence suggests broader systemic effects. DHEA appears to modulate immune cell activity, influence inflammatory pathways, and support bone metabolism through both direct effects and peripheral conversion to active sex steroids. It also interacts with central nervous system receptors, where it may influence mood, cognition, stress resilience, and neuroprotection.
DHEA-S acts primarily as a circulating reservoir, ensuring a steady supply of precursor hormone for tissue-specific steroid synthesis. This buffering role allows peripheral tissues to maintain hormonal responsiveness even when acute adrenal output fluctuates.
Age-related decline
DHEA-S levels peak in early adulthood and decline steadily from the mid-twenties onward, reaching approximately 10–20% of peak concentrations in older age. This decline parallels age-related reductions in muscle mass, bone density, immune responsiveness, and metabolic flexibility, although causality remains incompletely defined.
Interest in DHEA replacement has grown because of these associations, but clinical evidence remains mixed. While supplementation may modestly affect body composition or well-being in selected populations, its routine use is not supported by strong evidence and carries potential endocrine risks. The physiological decline of DHEA is therefore best understood as a marker of ageing rather than a single modifiable driver of age-related change.
Clinical Connections
Alterations in adrenal androgen production produce predictable clinical patterns because DHEA and DHEA-S reflect adrenal steroidogenic activity rather than gonadal function. Excess production most commonly arises from adrenal hyperplasia or adrenal tumours and leads to androgen excess, while deficiency reflects impaired adrenal output and reduced precursor availability for peripheral sex steroid synthesis.
Clinically, disturbances in DHEA and DHEA-S present with characteristic features that vary according to age and sex:
virilisation, acne, menstrual irregularities, or hirsutism in females with androgen excess
precocious puberty or accelerated growth and skeletal maturation in children
fatigue, reduced libido, and diminished sense of well-being in adrenal insufficiency
loss of adrenal androgen contribution to sex steroid balance in chronic adrenal disease
Measurement of DHEA-S is particularly valuable because its long half-life and stable circulating levels make it a reliable marker of adrenal androgen production. Elevated DHEA-S helps distinguish adrenal causes of hyperandrogenism from ovarian or testicular sources and is routinely used in the evaluation of congenital adrenal hyperplasia, adrenal tumours, and unexplained virilisation.
In adrenal insufficiency, low DHEA and DHEA-S levels contribute to reduced quality of life beyond cortisol deficiency alone, particularly in women. This has driven interest in DHEA supplementation, which has been explored for mood disorders, sexual dysfunction, and age-related decline. However, clinical evidence remains mixed, and concerns persist regarding long-term endocrine effects, inappropriate androgen exposure, and lack of clear outcome benefit. As a result, DHEA supplementation remains selective and experimental rather than routine clinical practice.
Concept Check
How does ACTH regulate the production of DHEA and DHEA-S in the adrenal cortex?
Why is DHEA considered a precursor hormone rather than a potent androgen itself?
What changes during adrenarche reflect rising adrenal androgen secretion?
How does DHEA contribute to sex hormone production in post-menopausal women?
Why is DHEA-S a more reliable clinical marker of adrenal androgen output than DHEA?